190 related articles for article (PubMed ID: 23623752)
1. First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.
Zhou K; Khokhar JY; Zhao B; Tyndale RF
Biochem Pharmacol; 2013 Jun; 85(12):1848-55. PubMed ID: 23623752
[TBL] [Abstract][Full Text] [Related]
2. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
McMillan DM; Tyndale RF
Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
[TBL] [Abstract][Full Text] [Related]
3. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
McMillan DM; Tyndale RF
Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
[TBL] [Abstract][Full Text] [Related]
4. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
McMillan DM; Miksys S; Tyndale RF
Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
[TBL] [Abstract][Full Text] [Related]
5. Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia.
Arguelles N; Richards J; El-Sherbeni AA; Miksys S; Tyndale RF
Biochem Pharmacol; 2022 Apr; 198():114949. PubMed ID: 35143755
[TBL] [Abstract][Full Text] [Related]
6. Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats.
McMillan DM; El-Sherbeni AA; Richards J; Tyndale RF
Brain Res Bull; 2020 Nov; 164():400-406. PubMed ID: 32926950
[TBL] [Abstract][Full Text] [Related]
7. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation.
Eckhardt K; Li S; Ammon S; Schänzle G; Mikus G; Eichelbaum M
Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456
[TBL] [Abstract][Full Text] [Related]
8. CYP2D in the brain impacts oral hydrocodone analgesia in vivo.
Richards J; Miksys S; Novalen M; Tyndale RF
Neuropharmacology; 2022 Dec; 221():109291. PubMed ID: 36241086
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
11. Sex and Estrous Cycle Differences in Analgesia and Brain Oxycodone Levels.
Arguelles N; Miksys S; Tyndale RF
Mol Neurobiol; 2021 Dec; 58(12):6540-6551. PubMed ID: 34581987
[TBL] [Abstract][Full Text] [Related]
12. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
[TBL] [Abstract][Full Text] [Related]
13. Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.
Caraco Y; Sheller J; Wood AJ
J Pharmacol Exp Ther; 1999 Jul; 290(1):413-22. PubMed ID: 10381807
[TBL] [Abstract][Full Text] [Related]
14. Functional phenotyping of the CYP2D6 probe drug codeine in the horse.
Gretler SR; Finno CJ; Kass PH; Knych HK
BMC Vet Res; 2021 Feb; 17(1):77. PubMed ID: 33581736
[TBL] [Abstract][Full Text] [Related]
15. A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.
Pai HV; Kommaddi RP; Chinta SJ; Mori T; Boyd MR; Ravindranath V
J Biol Chem; 2004 Jun; 279(26):27383-9. PubMed ID: 15051713
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the in vitro CYP450 mediated metabolism of the polymorphic CYP2D6 probe drug codeine in horses.
Knych HK; Baden RW; Gretler SR; McKemie DS
Biochem Pharmacol; 2019 Oct; 168():184-192. PubMed ID: 31295464
[TBL] [Abstract][Full Text] [Related]
17. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Cleary J; Mikus G; Somogyi A; Bochner F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition.
Eissing T; Lippert J; Willmann S
Mol Diagn Ther; 2012 Feb; 16(1):43-53. PubMed ID: 22352453
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
20. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]